Private equity investment in healthcare has continued to evolve since McGuireWoods examined various niche investment areas last year. Overall, valuations remain high, consolidation continues and the investment community is eyeing up larger buyers.
Please download this new McGuireWoods white paper for analysis of the current market and updated observations and insights on 19 key investment niches.
McGuireWoods is undertaking a yearlong effort to profile up-and-coming women leaders in private equity. This profile series complements our existing Women Leaders in Private Equity profile series, which will continue throughout 2019. For this profile, we are pleased to feature Becca Schlagenhauf Stull of Northwestern Mutual Capital. Access her profile.
To recommend a rising star for a future interview, email Amber Walsh at awalsh@mcguirewoods.com.
The McGuireWoods Healthcare Private Equity Team previously published a multi-part series highlighting some of the more active private equity (PE) investors in the healthcare space. Since the original publication, we have seen even more PE investors turn toward healthcare investments, new healthcare-focused funds form and healthcare PE deal activity continue at a staggering pace. Thus, we have decided to launch the Leading Private Equity Investors in Healthcare website.
The site highlights investors in a more current format. Please take a moment to check it out here and keep in mind that there will always be an option to suggest new investors, or to provide an update to your firm’s information (instructions on the site). We hope you’ll find this to be a valuable tool from our team as part of our ongoing service to the healthcare PE community.
Enhanced Healthcare Partners (EHP) has announced the closing of a new fund, with $300 million of committed capital and access to $600 million in total equity.
The firm will use the fund — Enhanced Healthcare Partners, L.P. — to pursue investments in lower middle market healthcare companies, specifically North American businesses with between $50 million and $250 million in enterprise value and within the physician services, pharma services, payor services and healthcare technology sectors.
Based in New York, EHP makes minority and majority investments in founder- and entrepreneur-led lower middle market companies. The firm employs a flexible investment strategy and seeks to invest $10 million to $50 million or more over the life of a portfolio company in a variety of flexible structures.
Cimarron Healthcare Capital (CHC) has acquired Infusion Management, according to a news release.
Infusion Management, headquartered in Thousand Oaks, Calif., is an infusion therapy management services organization providing services to Infusion for Health, a provider of infusion treatment services to patients in the Los Angeles market.
Founded in 2014, CHC is a private equity firm focusing on healthcare investments in the lower middle market. Based in Salt Lake City, Utah, CHC targets companies with $5 million to $75 million in revenue and up to $15 million of EBITDA for $5 million to $25 million equity investments.
Financial terms of the transaction were not disclosed.
McGuireWoods is undertaking a yearlong effort to profile up-and-coming women leaders in private equity. This profile series complements our existing Women Leaders in Private Equity profile series, which will continue throughout 2019. For this profile, we are pleased to feature Molly Williams Martin, a vice president with Silver Oak Services Partners. Access her profile.
To recommend a rising star for a future interview, email Amber Walsh at awalsh@mcguirewoods.com.
Please see below for the second installment of our interview series, A View From the Top. This series features interviews with C-suite leadership of private equity-backed portfolio companies. This installment features Scotte Hudsmith, CEO of Smile Doctors. The first installment, featuring Bill Southwick of QualDerm is available here. To recommend a leader for a future interview, email Holly Buckley at hbuckley@mcguirewoods.com.
As a reminder, our 17th annual Healthcare and Life Sciences Private Equity and Finance Conference is February 19 and 20 in Chicago. The save the date is available here. Please contact us for more information or to indicate an interest in participating on a panel.
Q: How closely are you involved with the business development/prospecting aspect of your platform?
Scotte Hudsmith: I am heavily involved in the business development process. Partially because I am passionate about growing but mostly because of our foundation and need for people to “fit” in our culture and for our culture to be a fit for those affiliating with us.
Smile Doctors is an organization that is driven by both organic and affiliation growth. We have built its foundation based on adding team members who have the right fit, skills and talent to succeed in our world. Our business development team does an excellent job of finding doctors who are the right fit to affiliate with us. We know that those affiliating with us possess the skills and talent as they have already built successful practices. I visit many of these doctors pre-affiliation to explain Smile Doctors’ success and the “why” behind our focus on fit and how this focus helps us create long-term value for our stakeholders.
Q: What do you believe is the most important personality trait in a business development leader?
SH: Tenacity followed by patience as a close second. Our business development team works with doctors who have spent many years of their life completing very expensive educations. Then they start or buy a practice and build an awesome reputation in their respective markets. Our business development team has to be able to walk through all of the reputation fears that may come from their peers or communities, explain the financial differences of our model versus the one they built and help them navigate the pre- and post-affiliation change cycles.
Q: How do you ensure the platform’s organizational culture is appropriately conveyed to potential targets?
SH: We live our culture every day, and each member of our team knows it so well that conveying it happens naturally. It is contagious. We like to say it is something that is caught, not taught.
Q: What is the toughest lesson you have learned with respect to business development?
SH: It is impossible to get into someone’s mind in a diligence process if they have alternative motives. You can find diligence information in the data and pick up on other behaviors along the way. However, if someone is telling you one thing and planning on another, it’s tough to uncover. An example is a doctor saying, “I want to stay and be a part of the team,” but they really are planning to check out and retire early and see you as the best exit. That is hard to uncover. We have had a few of these events and it’s tough on everyone, especially their former and post-affiliation team. We now have some ways to uncover these behaviors thanks to a great advisor.
Q: Can you share an inspiring business development success story?
SH: We have had a few doctors who were burned out and ready to retire when they affiliated with us. But once they joined our team, realized there is an easier way to practice with businesspeople handling the business side and discovered that they get to do what they love on the clinical side, it is a life-changing experience. Many of these individuals have now signed long-term employment agreements with the practices we support and have become some of the patients’ favorites. I was recently told by one doctor that they have changed more lives in their last few years affiliating with us than they ever did as a private practice owner because they have the time to really engage at a patient and team level.
Scotte Hudsmith serves as the chief executive officer (CEO) of Smile Doctors. He oversees the executive leadership team working to expand the company’s orthodontics experience across the United States. Since Hudsmith joined in 2014, Smile Doctors has grown from two Austin-area locations to nearly 200 locations in 16 states.
Hudsmith has more than 25 years of corporate leadership experience, including executive roles in finance, operations, business development and sales and marketing. He specializes in developing and implementing growth strategies in healthcare companies that are private equity-backed and has extensive experience coordinating mergers and acquisitions. Prior to joining Smile Doctors, he was CEO of Parental Health, a company he founded in 2009. He also previously served as executive vice president of finance and business development for Passport Health Communications, (now part of Experian Health).
In addition to his work at Smile Doctors, Hudsmith serves on the board and executive committee of the Association of Dental Support Organizations.
To contact Scotte Hudsmith, email scotte.hudsmith@smiledoctors.com.
Varsity Healthcare Partners (VHP) has announced the closing of its third private equity fund, VHP III, at $417 million.
VHP, with offices in Los Angeles and Stamford, Conn., is a lower-middle-market private equity firm focused on healthcare services. Founded in 2014, VHP aims to commit equity investments ranging from $20 million to $60 million.
With the closing of its third fund, total capital raised by VHP is approximately $816 million.
McGuireWoods is undertaking a yearlong effort to profile up-and-coming women leaders in private equity. This profile series complements our existing Women Leaders in Private Equity profile series, which will continue throughout 2019. For this profile, we are pleased to feature Renny Sie, a vice president of business development and investor relations at Boyne Capital. Access her profile.
To recommend a rising star for a future interview, email Amber Walsh at awalsh@mcguirewoods.com.
Council Capital has announced it has sold its stake in EspriGas to an entity affiliated with Kaltroco.
EspriGas, based in Atlanta, is a medical and industrial gas company.
Council Capital, based in Nashville, Tenn., is a healthcare-focused private equity firm. Council seems to make control and minority investments in lower-middle-market companies with enterprise values between $10 million and $50 million.
Kaltroco is a private investment company with operations in United States and Europe.
Terms of the transaction were not disclosed.